Lista de obras -

Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene

artículo científico publicado en 2009

An assessment of selected immune parameters of patients with Hodgkin's disease

artículo científico publicado en 2014

Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants

scientific article published on 01 May 2005

Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.

artículo científico publicado en 2016

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis

artículo científico publicado en 2008

Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia ⬇️

artículo científico publicado el 1 de diciembre de 2003

CD40L and IL-4 stimulation of acute lymphoblastic leukemia cells results in upregulation of mRNA level of FLICE--an important component of apoptosis

scientific article published on 01 January 2007

Can children with Hodgkin's disease be treated with chemotherapy only?

artículo científico publicado el 1 de enero de 2010

Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies

scientific article published on 01 March 2006

Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017

artículo científico publicado en 2018

Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).

artículo científico publicado en 2016

Concentrations of IL-15, IL-18, IFN-γ and activity of CD4(+), CD8(+) and NK cells at admission in children with viral bronchiolitis

artículo científico publicado en 2010

Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases

artículo científico publicado en 2002

Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years

artículo científico publicado en 2004

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience

scientific article published on 01 February 2020

GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia

artículo científico publicado en 2019

Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia

artículo científico publicado en 2019

Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.

artículo científico publicado en 2018

Influence of age on treatment results in children and adolescents with Hodgkin's disease

artículo científico publicado en 2004

Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial

scientific article published on 30 August 2019

Nasolacrimal duct obstruction after toxic epidermal necrolysis

scientific article published on 01 March 2012

Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress

artículo científico publicado en 2019

Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.

artículo científico publicado en 2017

Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications

artículo científico publicado en 2004

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia

artículo científico publicado en 2015

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia

artículo científico publicado en 2007

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

artículo científico publicado en 2007

Recurrent and novel disease-causing F8 variants in boys with severe haemophilia A in Poland

artículo científico publicado en 2019

Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland.

artículo científico publicado en 2015

Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia

scientific article published on 19 November 2020

Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland

artículo científico publicado en 2020

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.

artículo científico publicado en 2018

The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL

scientific article published on 17 July 2008

The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group

artículo científico publicado en 2006

The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response

artículo científico publicado en 2021

Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group

artículo científico publicado en 2004

[Analysis of the immunological reconstitution, effectiveness and safety of vaccination in children with cancer]

artículo científico publicado en 2010

[Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?]

artículo científico publicado en 2006

[KIR-NKAT2 expression and monocytoid dendritic cells transformation in children diagnosed for immune deficiency: a pilot study]

artículo científico publicado en 2009

[Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)]

artículo científico publicado en 2004

[Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience]

artículo científico publicado en 2006

Lista de obras de

Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene

An assessment of selected immune parameters of patients with Hodgkin's disease

Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants

Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.

Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis

Bone mass and bone mineral metabolism at diagnosis and after intensive treatment in children with acute lymphoblastic leukemia ⬇️

CD40L and IL-4 stimulation of acute lymphoblastic leukemia cells results in upregulation of mRNA level of FLICE--an important component of apoptosis

Can children with Hodgkin's disease be treated with chemotherapy only?

Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies

Clinical characteristics and analysis of treatment result in children with Ph-positive acute lymphoblastic leukaemia in Poland between 2005 and 2017

Clinical features and treatment outcomes of peripheral T-cell lymphoma in children. A current data report from Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).

Concentrations of IL-15, IL-18, IFN-γ and activity of CD4(+), CD8(+) and NK cells at admission in children with viral bronchiolitis

Course of viral hepatitis B and combined B and C hepatitis in children treated for neoplastic diseases

Decrease of dual hepatitis B and C virus infections in children with cancer: changes in risk factors over 30 years

First-line treatment failure in childhood acute lymphoblastic leukemia: The polish pediatric leukemia and lymphoma study group experience

GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Grade 3 and 4 Toxicity Profiles During Therapy of Childhood Acute Lymphoblastic Leukemia

Imatinib in the treatment of chronic myeloid leukemia in children and adolescents is effective and well tolerated: Report of the Polish Pediatric Study Group for the Treatment of Leukemias and Lymphomas.

Influence of age on treatment results in children and adolescents with Hodgkin's disease

Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial

Nasolacrimal duct obstruction after toxic epidermal necrolysis

Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress

Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.

Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

Recurrent and novel disease-causing F8 variants in boys with severe haemophilia A in Poland

Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland.

Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia

Six molecular patterns leading to hemophilia A phenotype in 18 females from Poland

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.

The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL

The health state evaluation in persons after therapy of Hodgkin's disease in childhood: report of the Polish Pediatric Leukemia/Lymphoma Study Group

The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy response

Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group

[Analysis of the immunological reconstitution, effectiveness and safety of vaccination in children with cancer]

[Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?]

[KIR-NKAT2 expression and monocytoid dendritic cells transformation in children diagnosed for immune deficiency: a pilot study]

[Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)]

[Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience]